StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
6
Publishing Date
2023 - 03 - 15
1
2023 - 03 - 10
1
2022 - 07 - 25
1
2022 - 03 - 01
1
2021 - 12 - 06
1
2021 - 08 - 11
1
Sector
Health technology
6
Manufacturing
2
Tags
Acute myeloid leukemia
2
Aml
2
Approval
1
Global
1
Growth
3
Leukemia
2
Market
3
Myeloid leukemia
2
N/a
6
Therapeutics
4
Entities
3m company
13
Abbott laboratories
119
Abbvie inc.
239
Abeona therapeutics inc.
7
Adaptimmune therapeutics plc
15
Alcon inc.
15
Alkermes plc
10
Amgen inc.
196
Astellas pharma inc
70
Astrazeneca plc
198
Autolus therapeutics plc
7
Bausch health companies inc.
74
Baxter international inc.
48
Becton, dickinson and company
19
Beigene, ltd.
7
Biogen inc.
54
Biontech se
10
Bluebird bio, inc.
11
Boston scientific corporation
17
Brainstorm cell therapeutics inc.
8
Bristol-myers squibb company
103
Csl ltd
9
Danaher corporation
11
Eli lilly and company
138
Endo international plc
20
General electric company
8
Genmab a/s
21
Gilead sciences, inc.
28
Glaxosmithkline plc
304
Grifols sa
10
Incyte corporation
21
Ionis pharmaceuticals, inc.
9
Jazz pharmaceuticals plc
14
Johnson & johnson
245
Koninklijke philips n.v.
19
Mallinckrodt plc
17
Medtronic plc
36
Morphosys ag
15
Novartis ag
1241
Novo nordisk a/s
28
Orange
8
Orchard therapeutics plc
9
Perrigo company
8
Pfizer, inc.
88
Precision biosciences, inc.
8
Reckitt benckiser group plc
9
Regeneron pharmaceuticals, inc.
13
Regenxbio inc.
12
Sanofi
329
Stryker corporation
12
Takeda pharmaceutical company limited
58
Terumo corp
9
Teva pharmaceutical industries limited
9
Teva pharmaceutical industries ltd
206
Thermo fisher scientific inc
51
Ucb s.a.
8
Uniqure n.v.
12
Vericel corporation
8
Viatris inc.
120
Xencor, inc.
11
Symbols
ABBV
7
ABST
1
ADCT
4
ADVM
1
AGIO
2
ALPMF
2
ALPMY
2
AMGN
6
AZN
1
AZNCF
1
BAC
1
CALT
2
CELU
1
CTIC
90
CYCC
2
FRG
1
GERN
1
GILD
1
GLAXF
3
GLPG
1
GLPGF
1
GSK
3
HMPT
1
HSIC
1
IMGN
1
IMNPQ
1
INCY
2
JAZZ
2
KURA
1
LLY
1
MEIP
2
MRK
1
NVS
6
NVSEF
5
RILY
1
SGEN
1
SNGX
1
SNY
5
SNYNF
5
TEVJF
4
Exchanges
Nasdaq
6
Nyse
6
Crawled Date
2023 - 03 - 15
1
2023 - 03 - 10
1
2022 - 07 - 25
1
2022 - 03 - 02
1
2021 - 12 - 06
1
2021 - 08 - 11
1
Crawled Time
00:00
1
06:00
1
12:00
2
15:20
1
23:00
1
Source
www.prnewswire.com
6
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Cti biopharma corp.
symbols :
Nvs
save search
The Global Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market is forecast to grow by $ 2061.88 mn during 2022-2027, accelerating at a CAGR of 7.96% during the forecast period
Published:
2023-03-15
(Crawled : 15:20)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
37.7%
|
O:
2.62%
H:
0.0%
C:
-3.57%
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
13.07%
|
O:
-1.0%
H:
1.39%
C:
1.02%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
18.48%
|
O:
-0.95%
H:
1.05%
C:
0.54%
ADCT
|
$4.96
11.71%
1.41%
1.2M
|
Health Technology
|
80.49%
|
O:
-0.81%
H:
3.48%
C:
-0.82%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
5.65%
|
O:
-1.09%
H:
1.45%
C:
1.24%
CTIC
|
$9.09
0.05%
11M
|
Health Technology
|
103.47%
|
O:
0.67%
H:
0.67%
C:
-2.22%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
15.62%
|
O:
-0.08%
H:
2.24%
C:
1.95%
global
therapeutics
market
Diffuse large B-cell lymphoma (DLBCL) therapeutics market size to increase by USD 2,061.88 million between 2022 and 2027; Growth driven by increasing approval of therapeutics - Technavio
Published:
2023-03-10
(Crawled : 23:00)
- prnewswire.com
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
CTIC
|
$9.09
0.05%
11M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
Email alert
Add to watchlist
ADCT
|
$4.96
11.71%
1.41%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
approval
therapeutics
growth
market
Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market Size to Grow by USD 1.79 billion, AbbVie Inc. and Bayer AG Among Key Vendors - Technavio
Published:
2022-07-25
(Crawled : 06:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
-6.05%
|
O:
0.0%
H:
0.0%
C:
0.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
34.65%
|
O:
3.12%
H:
0.06%
C:
0.06%
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
8.09%
|
O:
0.06%
H:
0.31%
C:
0.19%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
-5.53%
|
O:
0.76%
H:
0.19%
C:
-1.06%
ADCT
|
$4.96
11.71%
1.41%
1.2M
|
Health Technology
|
-39.67%
|
O:
0.14%
H:
0.0%
C:
-2.31%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
9.47%
|
O:
0.18%
H:
0.0%
C:
0.0%
CTIC
|
$9.09
0.05%
11M
|
Health Technology
|
41.89%
|
O:
-7.8%
H:
3.72%
C:
2.37%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
8.39%
|
O:
0.37%
H:
0.9%
C:
0.75%
therapeutics
market
JAK Inhibitors Market to Grow by USD 12.05 billion | Increasing Number of Awareness Campaigns to Boost Growth | Technavio
Published:
2022-03-01
(Crawled : 00:00)
- prnewswire.com
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
10.91%
|
O:
0.37%
H:
2.02%
C:
2.02%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
8.13%
|
O:
1.39%
H:
0.0%
C:
0.0%
ALPMY
|
$9.34
-1.11%
690K
|
Manufacturing
|
-42.7%
|
O:
-1.17%
H:
0.68%
C:
0.68%
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
5.31%
|
O:
-1.55%
H:
0.0%
C:
0.0%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
9.81%
|
O:
-0.22%
H:
2.4%
C:
1.27%
GLPG
|
$29.25
-0.81%
-0.82%
190K
|
Health Technology
|
-56.27%
|
O:
-2.66%
H:
0.35%
C:
-1.83%
CTIC
|
$9.09
0.05%
11M
|
Health Technology
|
222.52%
|
O:
6.03%
H:
13.88%
C:
12.71%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
9.64%
|
O:
-0.62%
H:
0.0%
C:
0.0%
growth
Global Acute Myeloid Leukemia (AML) Therapeutics Market Report 2021-2026: Ballooning Elderly Population - The Vital Growth Driver for AML Therapeutics
Published:
2021-12-06
(Crawled : 12:00)
- prnewswire.com
ALPMF
|
$9.594
43.47%
2.2K
|
Health Technology
|
-37.7%
|
O:
-1.49%
H:
1.45%
C:
0.92%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
18.68%
|
O:
2.02%
H:
0.04%
C:
-0.89%
IMNPQ
|
$0.001
|
Manufacturing
|
0.0%
|
O:
50.0%
H:
0.0%
C:
-33.33%
ALPMY
|
$9.34
-1.11%
690K
|
Manufacturing
|
-40.2%
|
O:
-3.39%
H:
3.45%
C:
3.3%
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
14.98%
|
O:
-0.57%
H:
0.0%
C:
0.0%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
37.97%
|
O:
1.57%
H:
0.0%
C:
0.0%
MEIP
|
$3.28
2.5%
2.44%
9.1K
|
Health Technology
|
17.22%
|
O:
-4.4%
H:
0.0%
C:
0.0%
JAZZ
|
$107.15
-1.61%
-1.63%
590K
|
Health Technology
|
-12.23%
|
O:
-2.16%
H:
0.0%
C:
0.0%
CYCC
|
$1.92
14.97%
13.02%
110K
|
Health Technology
|
-50.45%
|
O:
-5.93%
H:
0.0%
C:
0.0%
CTIC
|
$9.09
0.05%
11M
|
Health Technology
|
498.36%
|
O:
7.24%
H:
0.0%
C:
0.0%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
32.24%
|
O:
2.53%
H:
0.0%
C:
0.0%
AGIO
|
$29.03
0.8%
0.79%
500K
|
Health Technology
|
-19.4%
|
O:
-5.47%
H:
0.0%
C:
0.0%
myeloid leukemia
leukemia
therapeutics
growth
acute myeloid leukemia
aml
Global Acute Myeloid Leukemia (AML) Therapeutics Market to Reach $976.2 Billion by 2026
Published:
2021-08-11
(Crawled : 12:00)
- prnewswire.com
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
0.6%
|
O:
0.51%
H:
0.13%
C:
-0.27%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
41.56%
|
O:
0.3%
H:
0.16%
C:
-1.25%
MEIP
|
$3.28
2.5%
2.44%
9.1K
|
Health Technology
|
17.22%
|
O:
0.37%
H:
0.36%
C:
0.0%
JAZZ
|
$107.15
-1.61%
-1.63%
590K
|
Health Technology
|
-24.7%
|
O:
-0.09%
H:
1.32%
C:
0.35%
CYCC
|
$1.92
14.97%
13.02%
110K
|
Health Technology
|
-68.31%
|
O:
-0.19%
H:
0.19%
C:
-0.76%
CTIC
|
$9.09
0.05%
11M
|
Health Technology
|
214.71%
|
O:
1.73%
H:
0.34%
C:
-7.14%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
16.95%
|
O:
0.52%
H:
0.38%
C:
-0.44%
AGIO
|
$29.03
0.8%
0.79%
500K
|
Health Technology
|
-34.55%
|
O:
0.07%
H:
1.52%
C:
-0.32%
myeloid leukemia
leukemia
acute myeloid leukemia
aml
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.